Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Sodium-GLucose coTransporter-2 Inhibitors”

67 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 67 results

Post-approval studies (Phase 4)WithdrawnNCT02768220
What this trial is testing

The Effect of Sodium-Glucose Cotransporter 2 Inhibitors on Advanced Glycation End Products

Who this might be right for
SGLT-2 InhibitorsAdvanced Glycation End ProductsDiabetes
Northwell Health
Not applicableUnknownNCT06251453
What this trial is testing

Impact of Sodium-glucose Cotransporter 2 Inhibitors on Post-operative Atrial Fibrillation in Cardiothoracic Surgery

Who this might be right for
Atrial Fibrillation
Hamad Medical Corporation 3,280
Large-scale testing (Phase 3)UnknownNCT05601336
What this trial is testing

Of Sodium Glucose Cotransporter-2 Inhibitors on Metabolic, Hormonal and Clinical Parameters in PCO

Who this might be right for
PCO
Beni-Suef University 200
Post-approval studies (Phase 4)Not Yet RecruitingNCT07482943
What this trial is testing

The Effect of Dapagliflozin on Exercise and Cardiac Functional Status of Patients After Fontan Procedure

Who this might be right for
FontanHeart FailureDapagliflozin+2 more
The University of Hong Kong 30
Not applicableStudy completedNCT06903754
What this trial is testing

ISGLT2 in Patients Without DM With Acute MI

Who this might be right for
Acute Coronary SyndromesHeart Failure
Mohammed VI University Hospital 450
Not applicableStudy completedNCT06017544
What this trial is testing

GLP-1RAs) and SGLT2is Combination Therapy and MACEs in Patients with Type 2 Diabetes.

Who this might be right for
Diabetes Mellitus, Type 2Myocardial Infarction
University of Campania Luigi Vanvitelli 257
Very early researchLooking for participantsNCT06430684
What this trial is testing

Feasibility Trial of Sodium-GLucose coTransporter 2 INhibitors in Pediatric Chronic KIDney DiSease

Who this might be right for
Chronic Kidney DiseasesPediatric Kidney Disease
Ann & Robert H Lurie Children's Hospital of Chicago 40
Post-approval studies (Phase 4)Not Yet RecruitingNCT06350487
What this trial is testing

The Efficacy of Enavogliflozin in Heart Failure With Preserved Ejection Fraction

Who this might be right for
Heart Failure, Preserved Ejection Fraction
Samsung Medical Center 154
Testing effectiveness (Phase 2)Looking for participantsNCT07018622
What this trial is testing

Protecting the Kidney's Proximal Tubules From Platinum-Based Chemotherapy Toxicity

Who this might be right for
Solid TumorsCisplatin Nephrotoxicity
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran 46
Post-approval studies (Phase 4)Not Yet RecruitingNCT07547878
What this trial is testing

Rapid and Simultaneous Initiation of Four Guideline-Directed CKD Therapies (RAPID-CKD)

Who this might be right for
Chronic Kidney DiseaseType 2 Diabetes
Baylor Research Institute 64
Large-scale testing (Phase 3)Ended earlyNCT05468203
What this trial is testing

PREVENTion With Sglt-2 Inhibition of Acute Kidney Injury in Intensive Care

Who this might be right for
Acute Kidney Injury
The George Institute 51
Not applicableLooking for participantsNCT06932081
What this trial is testing

Adult Congenital Heart Disease International EValuation of the Effectiveness of SGLT2i Registry

Who this might be right for
Adult Congenital Heart DiseaseCongenital Heart DiseaseSystemic Right Ventricle+5 more
Leiden University Medical Center 400
Early research (Phase 1)Looking for participantsNCT05521984
What this trial is testing

Targeting Pediatric Brain Tumors and Relapsed/Refractory Solid Tumors With Sodium Glucose Cotransporter 2 Inhibitors (SGLT2i)

Who this might be right for
Pediatric Brain TumorPediatric Solid Tumor
Washington University School of Medicine 20
Post-approval studies (Phase 4)Looking for participantsNCT07405216
What this trial is testing

Efficacy and Safety of Sodium-Glucose Cotransporter-2 Inhibitors in Adolescents With Early Stages of Chronic Kidney Disease

Who this might be right for
Chronic Kidney Disease (Mild to Moderate)AlbuminuriaAdolescent+1 more
Centenario Hospital Miguel Hidalgo 200
Large-scale testing (Phase 3)UnknownNCT05310916
What this trial is testing

Effect of SGLT2i on Diabetic Retinopathy in Type 2 Diabetes Mellitus Patients

Who this might be right for
Diabetic Retinopathy
Nidae Alaa 60
Not applicableUnknownNCT06268977
What this trial is testing

Using of SGLt2 Inhibitors in Patients With Type 2 DM

Who this might be right for
Type 2 Diabetes
Assiut University 400
Not applicableUnknownNCT06344247
What this trial is testing

Comparison of the Efficacy and Safety of SGLT2i and GLP-1 Receptor Agonists in Obese Patients With Kidney Disease

Who this might be right for
ObesityChronic Kidney Diseases
RenJi Hospital 48
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07146880
What this trial is testing

Empagliflozin as a Potential Therapeutic Solution for Patients With Brugada Syndrome

Who this might be right for
Brugada Syndrome (BrS)
National Taiwan University Hospital 10
Post-approval studies (Phase 4)Looking for participantsNCT06562582
What this trial is testing

STunning in Acute Myocardial Infarction - BAS

Who this might be right for
Myocardial Infarct
Vastra Gotaland Region 120
Post-approval studies (Phase 4)Study completedNCT06012279
What this trial is testing

Clinical Outcomes of Dapagliflozin in Acute Heart Failure With Reduced Ejection Fraction (CODA-HFrEF)

Who this might be right for
Acute Heart Failure
Cairo University 117
Load More Results